Kenneth A. Myszkowski
Equibles does not estimate personal net worth.
About Kenneth A. Myszkowski
Kenneth A. Myszkowski was last confirmed as CFO at Arrowhead Pharmaceuticals, Inc. (ARWR) in a filing dated January 29, 2025. The proxy statement of Arrowhead Pharmaceuticals, Inc. reports total compensation of $3,512,376 for Kenneth A. Myszkowski in fiscal 2024, including a base salary of $592,369. Disclosed compensation is on record for 5 fiscal years.
Affiliation history
-
Start not stated–2025-01-29
Last confirmed by a filing; no departure on record
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Arrowhead Pharmaceuticals, Inc. (ARWR) | Chief Financial Officer | $592,369 | $3,512,376 |
| 2023 | Arrowhead Pharmaceuticals, Inc. (ARWR) | Chief Financial Officer | $568,128 | $3,119,143 |
| 2022 | Arrowhead Pharmaceuticals, Inc. (ARWR) | Chief Financial Officer | $509,648 | $4,739,552 |
| 2021 | Arrowhead Pharmaceuticals, Inc. (ARWR) | Chief Financial Officer | $484,865 | $5,333,570 |
| 2020 | Arrowhead Pharmaceuticals, Inc. (ARWR) | Chief Financial Officer | $463,750 | $6,081,852 |
Recent activity
No call appearances or filed executive changes recorded yet.